Author:
Beck William T.,Danks Mary K.
Reference197 articles.
1. Ahmed, N. K., and Vasanthakumar, G., 1987, Characterization of daunorubicin resistance in K562 leukemia cells lacking daunorubicin reductase activity, Eur. J. Cancer Clin. Oncol. 23:1329–1336.
2. Akiyama, S.-I., Fojo, A., Hanover, J. A., Pastan, I., and Gottesman, M. M., 1985, Isolation and genetic characterization of human KB cell lines resistant to multiple drugs. Somatic Cell Mol. Genet. 11:117–126.
3. Akiyama, S.-I., Cornwell, M. M., Kuwano, M., Pastan, I., and Gottesman, M. M., 1988, Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-glycoprotein by a vinblastine analog. Mol. Pharmacol. 33:144–147.
4. Allavena, P., Grandi, M., D’Incalci, M., Geri, O., Giuliani, F. C., and Mantovani, A., 1987, Human tumor cell lines with pleiotropic drug resistance are efficiently killed by interleukin-2 activated killer cells and by activated monocytes. Int. J. Cancer 40:104–107.
5. Bakic, M., Beran, M., Andersson, B. S., Silberman, L., Estey, E., and Zwelling, L. A., 1986, The production of topoisomerase II-mediated DNA cleavage in human leukemia cells predicts their susceptibility to 4′-(9-acridinylamino)-methanesulfon-m-anisidide (m-AMSA). Biochem. Biophys. Res. Commun. 134:638–645.
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献